High Pesticide Exposure Events and Olfactory Dysfunction: Integrating Subjective and Objective Evidence from Agricultural Cohorts

High Pesticide Exposure Events and Olfactory Dysfunction: Integrating Subjective and Objective Evidence from Agricultural Cohorts

Emerging evidence links high pesticide exposure events (HPEEs) in farmers to increased self-reported olfactory dysfunction, though objective smell testing yields inconclusive associations, highlighting critical gaps and methodological considerations in assessing pesticide-related olfactory impairment.
Teplizumab Preserves Beta Cell Function in Youth with Newly Diagnosed Type 1 Diabetes: Insights from the PROTECT Trial Per-Protocol Analysis

Teplizumab Preserves Beta Cell Function in Youth with Newly Diagnosed Type 1 Diabetes: Insights from the PROTECT Trial Per-Protocol Analysis

The PROTECT trial's per-protocol analysis confirms teplizumab's efficacy in preserving beta cell function, reducing insulin needs, and improving glycemic control in children and adolescents newly diagnosed with stage 3 type 1 diabetes, regardless of HLA subtype or autoantibody profile.
Comparative Real-World Outcomes of Hypothermic Oxygenated and Normothermic Machine Perfusion in Liver Transplantation

Comparative Real-World Outcomes of Hypothermic Oxygenated and Normothermic Machine Perfusion in Liver Transplantation

This international cohort study evaluates hypothermic oxygenated perfusion (HOPE) versus normothermic machine perfusion (NMP) in liver transplantation, revealing comparable high graft survival despite differing donor risk profiles and highlighting the need for further research on NMP benefits in high-risk grafts.
Determinants of Serum Dexamethasone Levels During the 1-mg Overnight Dexamethasone Suppression Test: Clinical and Pharmacological Insights

Determinants of Serum Dexamethasone Levels During the 1-mg Overnight Dexamethasone Suppression Test: Clinical and Pharmacological Insights

This study investigates clinical and pharmacological factors influencing serum dexamethasone levels during the 1-mg overnight dexamethasone suppression test, revealing age and BMI as key determinants and highlighting the limited impact of renal function and concurrent medications after adjustment.